HealthCare Ventures IX, L.P. 4
4 · LEAP THERAPEUTICS, INC. · Filed Aug 1, 2018
Insider Transaction Report
Form 4
HealthCare Ventures IX, L.P.
10% Owner
Transactions
- Other
Warrant (Right to Buy)
2018-07-30−1,057,769→ 0 totalExercise: $6.08From: 2017-11-14Exp: 2024-11-14→ Common Stock (1,057,769 underlying)
Footnotes (1)
- [F1]HealthCare Ventures IX, L.P. ("HCV IX") distributed these warrants to its limited partners on a pro rata basis, for no consideration. In the distribution, Eli Lilly and Company, a 5% or greater stockholder of the Company and limited partner of HCV IX, received a warrant to purchase 331,221 shares of common stock. No shares of outstanding common stock were distributed. HCV IX continues to hold 3,573,376 shares of common stock, which represents 24.3% of the outstanding common stock.